A variety of ADRs belonging to movement disorders (e.g., extrapyramidal disorder, Parkinsonism, and dyskinesia) were associated with several targets, including OPRK1 (9 drugs), CHRM2 (8 drugs), and ADRA1A (5 drugs). This evidence concerns the gene ADRA1A and Dyskinesia.